In fact, plasma levels of soluble HLA-G are higher in patients with pancreatic cancer compared to healthy donors, and soluble HLA-G levels inversely correlate with the number of peripheral activated T cells (22). The gene discussed is HLA-G; the disease is familial pancreatic carcinoma.